You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pdr001

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

Recruiting
  • Thyroid Cancer
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 19, 2023

Metastatic Colorectal Cancer Trial in Boston (Dabrafenib, Trametinib, PDR001)

Recruiting
  • Metastatic Colorectal Cancer
  • Boston, Massachusetts
  • +1 more
Jun 24, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • +6 more
  • NZV930
  • +2 more
  • Tampa, Florida
  • +9 more
Nov 2, 2022

Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer

Terminated
  • Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022

Advanced Malignancies Trial in Worldwide (MBG453, PDR001, Decitabine)

Terminated
  • Advanced Malignancies
  • Baltimore, Maryland
  • +13 more
Sep 20, 2022

Metastatic and Advanced Solid Tumors Trial in United States (NIZ985, PDR001)

Completed
  • Metastatic and Advanced Solid Tumors
  • Bethesda, Maryland
  • +6 more
Mar 22, 2022

Solid Tumors Trial in Worldwide (KAZ954, PDR001, NIR178)

Recruiting
  • Solid Tumors
  • Los Angeles, California
  • +12 more
Dec 23, 2022

Multiple Myeloma Trial in Worldwide (PDR001, CJM112, LCL161)

Completed
  • Multiple Myeloma
  • PDR001
  • +2 more
  • Phoenix, Arizona
  • +7 more
Feb 7, 2022

NSCLC Trial in Worldwide (PDR001, Cisplatin, Gemcitabine)

Terminated
  • Non-small Cell Lung Cancer
  • PDR001
  • +6 more
  • Fayetteville, Arkansas
  • +22 more
Aug 11, 2022

Metastatic Colorectal Cancer Trial in Sutton (PDR001, bevacizumab, mFOLFOX6)

Terminated
  • Metastatic Colorectal Cancer
  • PDR001
  • +2 more
  • Sutton, Surrey, United Kingdom
    Novartis Investigative Site
Oct 7, 2021

Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Trial in Worldwide (PDR001, ACZ885, CJM112)

Completed
  • Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
  • PDR001
  • +4 more
  • Baltimore, Maryland
  • +22 more
Mar 15, 2022

Breast Cancer, Lung Cancer, Hepatocellular Cancer Trial in Worldwide (NIS793, PDR001)

Completed
  • Breast Cancer
  • +5 more
  • Nashville, Tennessee
  • +11 more
Jan 28, 2022

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in

Completed
  • Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
  • PDR001
  • +5 more
  • Santa Monica, California
  • +24 more
Mar 11, 2022

Advanced Hepatocellular Carcinoma Trial in Worldwide (PDR001, INC280)

Completed
  • Advanced Hepatocellular Carcinoma
  • Toronto, Ontario, Canada
  • +16 more
Jul 29, 2021

Advanced Solid Tumors Trial in Worldwide (LAG525, PDR001)

Completed
Has Results
  • Advanced Solid Tumors
  • New York, New York
  • +23 more
Jan 17, 2022

Histologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard Treatment

Active, not recruiting
  • Histologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard Treatment
  • PDR001
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
May 5, 2021

Triple-negative Breast Cancer Trial in Worldwide (LAG525, Spartalizumab, Carboplatin)

Completed
Has Results
  • Triple-negative Breast Cancer
  • Chandler, Arizona
  • +32 more
Jan 27, 2023

Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)

Completed
Has Results
  • Triple Negative Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +19 more
Jul 12, 2021

Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

Recruiting
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jun 13, 2022

NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

Terminated
  • NSCLC
  • +3 more
  • Boston, Massachusetts
  • +17 more
Dec 20, 2022

Solid Tumors, Lymphomas Trial in Worldwide (GWN323, PDR001)

Completed
  • Solid Tumors
  • Lymphomas
  • Chicago, Illinois
  • +8 more
Feb 18, 2021

Hepatocellular Carcinoma Trial in Worldwide (PDR001, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Detroit, Michigan
  • +8 more
Dec 16, 2020

Well-differentiated Non-functional NET of Thoracic Origin, Well-differentiated Non-functional NET of Gastrointestinal Origin,

Completed
Has Results
  • Well-differentiated Non-functional NET of Thoracic Origin
  • +3 more
  • PDR001
  • Duarte, California
  • +34 more
Mar 16, 2021

Advanced Solid Tumors Trial in Worldwide (PDR001)

Recruiting
  • Advanced Solid Tumors
  • PDR001
  • New York, New York
  • +42 more
Jan 23, 2023